Carroll Margaret D, Kruszon-Moran Deanna, Tolliver Eric
Natl Health Stat Report. 2019 Sep(127):1-16.
Objectives-Guidelines for lowering cholesterol have focused on total and lowdensity lipoprotein cholesterol (LDL-C). Although the emphasis remains on LDL-C, more attention is now being given to apolipoprotein B (apo B) and non-high-density lipoprotein cholesterol (non-HDL-C). This report presents trends in mean apo B, non-HDL-C, and LDL-C in adults aged 20 and over from 2005-2006 through 2015-2016. Methods-Data from the 2005-2016 National Health and Nutrition Examination Surveys were used to conduct trend analyses. Means and standard errors of the mean for apo B (n = 13,802), non-HDL-C (n = 30,921), and LDL-C (n = 13,559) are presented overall and by sex, stratified by age, race and Hispanic origin, and body mass index (BMI) category for each 2-year survey cycle. Trends over time were tested using orthogonal contrast matrices and piecewise and multiple linear regression. Results-In men, apo B declined from 98 mg/dL in 2005-2006 to 93 mg/dL in 2011-2012, but did not change after 2011-2012. Declining trends were also seen for men in non-HDL-C (147 to 141 mg/dL) and LDL-C (116 to 114 mg/dL) from 2005-2006 to 2015-2016. For women, age-adjusted mean apo B declined from 94 mg/dL in 2005-2006 to 91 mg/dL in 2015-2016. Non-HDL-C and LDL-C in women did not change significantly from 2005-2006 to 2011-2012, but non-HDL-C declined from 141 mg/dL in 2011-2012 to 133 mg/dL in 2015-2016, and LDL-C declined from 117 mg/dL in 2011-2012 to 111 mg/dL in 2015-2016. With the exception of LDL-C in men, these trends persisted after controlling for age, race and Hispanic origin, BMI, and lipid-lowering medication use. Conclusions-From 2005-2006 to 2015-2016, significant but different declining trends in apo B, non-HDL-C, and LDL-C were seen in men and women. In general, differences in age, race and Hispanic origin, BMI category, and lipid-lowering medication use did not explain the trends.
目标——降低胆固醇的指南一直聚焦于总胆固醇和低密度脂蛋白胆固醇(LDL-C)。尽管重点仍然是LDL-C,但现在对载脂蛋白B(apo B)和非高密度脂蛋白胆固醇(non-HDL-C)的关注更多了。本报告呈现了2005 - 2006年至2015 - 2016年20岁及以上成年人的平均apo B、non-HDL-C和LDL-C的变化趋势。方法——使用2005 - 2016年国家健康和营养检查调查的数据进行趋势分析。总体以及按性别呈现apo B(n = 13,802)、non-HDL-C(n = 30,921)和LDL-C(n = 13,559)的均值和均值标准误,并按年龄、种族和西班牙裔血统以及体重指数(BMI)类别在每个2年调查周期进行分层。使用正交对比矩阵以及分段和多元线性回归检验随时间的趋势。结果——在男性中,apo B从2005 - 2006年的98毫克/分升降至2011 - 2012年的93毫克/分升,但在2011 - 2012年后没有变化。从2005 - 2006年到2015 - 2016年,男性的non-HDL-C(从147毫克/分升降至141毫克/分升)和LDL-C(从116毫克/分升降至114毫克/分升)也呈现下降趋势。对于女性,年龄调整后的平均apo B从2005 - 2006年的94毫克/分升降至2015 - 2016年的91毫克/分升。女性的non-HDL-C和LDL-C在2005 - 至2011 - 2012年没有显著变化,但non-HDL-C从2011 - 2012年的141毫克/分升降至2015 - 2016年的133毫克/分升,LDL-C从2011 - 2012年的117毫克/分升降至2015 - 2016年的111毫克/分升。除男性的LDL-C外,在控制了年龄、种族和西班牙裔血统、BMI以及降脂药物使用情况后,这些趋势仍然存在。结论——从2005 - 2006年到2015 - 2016年,男性和女性的apo B、non-HDL-C和LDL-C呈现出显著但不同的下降趋势。总体而言,年龄、种族和西班牙裔血统、BMI类别以及降脂药物使用情况的差异并不能解释这些趋势。